Bioventus Inc.: Form 8-K, filed Sep 1, 2022
Filed with the SEC on Sep 1, 2022 and accepted by EDGAR at Aug 31, 2022, 18:04 ET.
Items reported
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001628280-22-024088. Last ingested by Listed: Nov 2, 2026, 17:44 ET. Listed shows no prices and gives no investment advice.